Alzheimer’s Drug Research – A Ray of Hope
Read Finding Suggests New Target for Alzheimer’s Drugs, by New York Times science reporter Gina Kolata, to learn about a new direction in Alzheimer’s disease research. In her article Kolata writes about Nobel Prize winner (2000) Paul Greengard, an 84-year-old scientist, who is studying a specific protein, gamma secretase activating protein, that can possibly be targeted by drugs to stop the production of beta amyloid, which is responsible for the progression of Alzheimer’s disease. Dr. Greengard is the Vincent Astor Professor and director of the Fisher Center for Alzheimer’s Research, at Rockefeller University in New York City. An article about his research (abstract) is published in Nature. Moreover, a quick search on PubMed reveals that Professor Greengard’s name has appeared on 16 scientific papers published this year. Read more »







